Washington University School of Medicine SC-2 — St Louis, Missouri

Washington University School of Medicine SC-2 is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Washington University School of Medicine SC-2 has participated in 1 clinical trials.

Therapeutic areas: Tuberous Sclerosis Complex-associated Refractory Seizures.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St Louis

Browse all research sites in Missouri · View every site in St Louis

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine SC-2?

Washington University School of Medicine SC-2 has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine SC-2 conducted?

Washington University School of Medicine SC-2 has 1 clinical trials on record. Their work covers Tuberous Sclerosis Complex-associated Refractory Seizures.

Is Washington University School of Medicine SC-2 accredited by Crixeo Clinical Trials?

Washington University School of Medicine SC-2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine SC-2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.